Future studies will determine whether and how the environmental cues change Lkb1 in Treg cells to affect their stability/function under physiological and pathological conditions, and whether Lkb1 can be targeted to treat Treg-cell-related immune diseases. Here, STK11 is linked to immune system disorder.